|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gleason DF: Classification of prostatic
carcinomas. Cancer Chemother Rep. 50:125–128. 1966.PubMed/NCBI
|
|
3
|
Albertsen PC, Hanley JA, Gleason DF and
Barry MJ: Competing risk analysis of men aged 55 to 74 years at
diagnosis managed conservatively for clinically localized prostate
cancer. JAMA. 280:975–980. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Epstein JI, Allsbrook WC Jr, Amin MB and
Egevad LL; ISUP Grading Committee, : The 2005 international society
of urological pathology (ISUP) consensus conference on gleason
grading of prostatic carcinoma. Am J Surg Pathol. 29:1228–1242.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Epstein JI, Partin AW, Sauvageot J and
Walsh PC: Prediction of progression following radical
prostatectomy. A multivariate analysis of 721 men with long-term
follow-up. Am J Surg Pathol. 20:286–292. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siadat F, Sykes J, Zlotta AR, Aldaoud N,
Egawa S, Pushkar D, Kuk C, Bristow RG, Montironi R and van der
Kwast T: Not all Gleason pattern 4 prostate cancers are created
equal: A study of latent prostatic carcinomas in a
cystoprostatectomy and autopsy series. Prostate. 75:1277–1284.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kovi J, Jackson MA and Heshmat MY: Ductal
spread in prostatic carcinoma. Cancer. 56:1566–1573. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McNeal JE and Yemoto CE: Spread of
adenocarcinoma within prostatic ducts and acini. Morphologic and
clinical correlations. Am J Surg Pathol. 20:802–814. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo CC and Epstein JI: Intraductal
carcinoma of the prostate on needle biopsy: Histologic features and
clinical significance. Mod Pathol. 19:1528–1535. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Robinson BD and Epstein JI: Intraductal
carcinoma of the prostate without invasive carcinoma on needle
biopsy: Emphasis on radical prostatectomy findings. J Urol.
184:1328–1333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cohen RJ, Chan WC, Edgar SG, Robinson E,
Dodd N, Hoscek S and Mundy IP: Prediction of pathological stage and
clinical outcome in prostate cancer: An improved pre-operative
model incorporating biopsy-determined intraductal carcinoma. Br J
Urol. 81:413–418. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wilcox G, Soh S, Chakraborty S, Scardino
PT and Wheeler TM: Patterns of high-grade prostatic intraepithelial
neoplasia associated with clinically aggressive prostate cancer.
Hum Pathol. 29:1119–1123. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van der Kwast T, Al Daoud N, Collette L,
Sykes J, Thoms J, Milosevic M, Bristow RG, van Tienhoven G, Warde
P, Mirimanoff RO and Bolla M: Biopsy diagnosis of intraductal
carcinoma is prognostic in intermediate and high risk prostate
cancer patients treated by radiotherapy. Eur J Cancer.
48:1318–1325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dong F, Yang P, Wang C, Wu S, Xiao Y,
McDougal WS, Young RH and Wu CL: Architectural heterogeneity and
cribriform pattern predict adverse clinical outcome for Gleason
grade 4 prostatic adenocarcinoma. Am J Surg Pathol. 37:1855–1861.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kryvenko ON, Gupta NS, Virani N, Schultz
D, Gomez J, Amin A, Lane Z and Epstein JI: Gleason score 7
adenocarcinoma of the prostate with lymph node metastases: Analysis
of 184 radical prostatectomy specimens. Arch Pathol Lab Med.
137:610–617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kweldam CF, Wildhagen MF, Steyerberg EW,
Bangma CH, van der Kwast TH and van Leenders GJ: Cribriform growth
is highly predictive for postoperative metastasis and
disease-specific death in Gleason score 7 prostate cancer. Mod
Pathol. 28:457–464. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Trudel D, Downes MR, Sykes J, Kron KJ,
Trachtenberg J and van der Kwast TH: Prognostic impact of
intraductal carcinoma and large cribriform carcinoma architecture
after prostatectomy in a contemporary cohort. Eur J Cancer.
50:1610–1616. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shah RB, Magi-Galluzzi C, Han B and Zhou
M: Atypical cribriform lesions of the prostate: Relationship to
prostatic carcinoma and implication for diagnosis in prostate
biopsies. Am J Surg Pathol. 34:470–477. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iczkowski KA, Egevad L, Ma J,
Harding-Jackson N, Algaba F, Billis A, Camparo P, Cheng L, Clouston
D, Comperat EM, et al: Intraductal carcinoma of the prostate:
Interobserver reproducibility survey of 39 urologic pathologists.
Ann Diagn Pathol. 18:333–342. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
You JS and Jones PA: Cancer genetics and
epigenetics: Two sides of the same coin? Cancer Cell. 22:9–20.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sharma S, Kelly TK and Jones PA:
Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Strand SH, Orntoft TF and Sorensen KD:
Prognostic DNA methylation markers for prostate cancer. Int J Mol
Sci. 15:16544–16576. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kron KJ, Liu L, Pethe VV, Demetrashvili N,
Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L,
van der Kwast TH and Bapat B: DNA methylation of HOXD3 as a marker
of prostate cancer progression. Lab Invest. 90:1060–1067. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu L, Kron KJ, Pethe VV, Demetrashvili N,
Nesbitt ME, Trachtenberg J, Ozcelik H, Fleshner NE, Briollais L,
van der Kwast TH and Bapat B: Association of tissue promoter
methylation levels of APC, TGFβ2, HOXD3 and RASSF1 with prostate
cancer progression. Int J Cancer. 129:2454–2462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kron K, Liu L, Trudel D, Pethe V,
Trachtenberg J, Fleshner N, Bapat B and van der Kwast T:
Correlation of ERG expression and DNA methylation biomarkers with
adverse clinicopathologic features of prostate cancer. Clin Cancer
Res. 18:2896–2904. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eads CA, Danenberg KD, Kawakami K, Saltz
LB, Blake C, Shibata D, Danenberg PV and Laird PW: MethyLight: A
high-throughput assay to measure DNA methylation. Nucleic Acids
Res. 28:E322000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Campan M, Weisenberger DJ, Trinh B and
Laird PW: MethyLight. Methods Mol Biol. 507:325–337. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Van der Kwast TH: Prognostic prostate
tissue biomarkers of potential clinical use. Virchows Arch.
464:293–300. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
He TC, Sparks AB, Rago C, Hermeking H,
Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW:
Identification of c-MYC as a target of the APC pathway. Science.
281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Thaler S, Hähnel PS, Schad A, Dammann R
and Schuler M: RASSF1 mediates p21Cip1/Waf1-dependent cell cycle
arrest and senescence through modulation of the Raf-MEK-ERK pathway
and inhibition of Akt. Cancer Res. 69:1748–1757. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farin HF, Mansouri A, Petry M and Kispert
A: T-box protein Tbx18 interacts with the paired box protein Pax3
in the development of the paraxial mesoderm. J Biol Chem.
283:25372–25380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mayanil CS, George D, Freilich L, Miljan
EJ, Mania-Farnell B, McLone DG and Bremer EG: Microarray analysis
detects novel Pax3 downstream target genes. J Biol Chem.
276:49299–49309. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Esteller M, Sparks A, Toyota M,
Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G,
Sidransky D, Meltzer SJ, et al: Analysis of adenomatous polyposis
coli promoter hypermethylation in human cancer. Cancer Res.
60:4366–4371. 2000.PubMed/NCBI
|
|
34
|
Pfeifer GP and Dammann R: Methylation of
the tumor suppressor gene RASSF1 in human tumors. Biochemistry
(Mosc). 70:576–583. 2005. View Article : Google Scholar : PubMed/NCBI
|
